|
CCNG2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.48090000005186E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.001040E-01 |
| Normal-vs-Stage2 |
1.219760E-01 |
| Normal-vs-Stage3 |
1.84774417988365E-12 |
| Normal-vs-Stage4 |
1.60199631338287E-11 |
| Stage1-vs-Stage2 |
5.034400E-01 |
| Stage1-vs-Stage3 |
7.24140003516283E-09 |
| Stage1-vs-Stage4 |
6.25970000278642E-08 |
| Stage2-vs-Stage3 |
1.343630E-02 |
| Stage2-vs-Stage4 |
9.958300E-03 |
| Stage3-vs-Stage4 |
7.178200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.06660000004566E-06 |
| Normal-vs-AfricanAmerican |
9.862700E-03 |
| Normal-vs-Asian |
9.310400E-02 |
| Caucasian-vs-AfricanAmerican |
4.843200E-01 |
| Caucasian-vs-Asian |
5.274000E-01 |
| AfricanAmerican-vs-Asian |
8.400600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.22980000000417E-06 |
| Normal-vs-Female |
1.766350E-04 |
| Male-vs-Female |
9.807200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.558040E-01 |
| Normal-vs-Age(41-60Yrs) |
1.644080E-03 |
| Normal-vs-Age(61-80Yrs) |
7.90620000024056E-07 |
| Normal-vs-Age(81-100Yrs) |
6.27699999977693E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.399400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.860000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.188800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.337170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.250400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.336000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.354800E-01 |
| Normal-vs-Grade 2 |
6.780000E-02 |
| Normal-vs-Grade 3 |
4.56750000044082E-08 |
| Normal-vs-Grade 4 |
1.62458935193399E-12 |
| Grade 1-vs-Grade 2 |
1.232570E-01 |
| Grade 1-vs-Grade 3 |
6.151900E-02 |
| Grade 1-vs-Grade 4 |
7.239800E-03 |
| Grade 2-vs-Grade 3 |
1.822190E-03 |
| Grade 2-vs-Grade 4 |
8.63720206467633E-12 |
| Grade 3-vs-Grade 4 |
2.16429999999601E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.121000E-01 |
| Normal-vs-ccB subtype |
2.18220000000047E-05 |
| ccA subtype-vs-ccB subtype |
9.643200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.3200000000021E-05 |
| Normal-vs-N1 |
5.562500E-03 |
| N0-vs-N1 |
1.318590E-01 |
|
|
